Back to Search
Start Over
Cabazitaxel: Lack of efficacy following off-label use: case report.
- Source :
-
Reactions Weekly . 10/28/2023, Vol. 1980 Issue 1, p102-102. 1p. - Publication Year :
- 2023
-
Abstract
- During the hospitalisation, another total body CT scan in August 2022 revealed further significant progressive disease and the occurrence of peritoneal carcinomatosis, indicating lack of efficacy with off-label cabazitaxel. On presentation, CT scan of the chest and the abdomen-pelvis revealed pathological lymph nodes in the left inguinal region, in the para-rectal adipose tissue and along the iliac and para-aortic vessels, which was also confirmed with an FDG-PET-scan. A restaging CT scan (3 May 2022) revealed stable lymph node disease and a slight increase of the prostate gland. [Extracted from the article]
- Subjects :
- *OFF-label use (Drugs)
*CABAZITAXEL
*BASAL cell carcinoma
*PROSTATE
Subjects
Details
- Language :
- English
- ISSN :
- 01149954
- Volume :
- 1980
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Reactions Weekly
- Publication Type :
- Periodical
- Accession number :
- 173274576
- Full Text :
- https://doi.org/10.1007/s40278-023-48294-y